Impact of Clopidogrel Therapy on Mortality and Cancer in Patients With Cardiovascular and Cerebrovascular Disease-Reference-Cited by-同舟云学术

Impact of Clopidogrel Therapy on Mortality and Cancer in Patients With Cardiovascular and Cerebrovascular Disease

Published:2018-01 Issue:1 Volume:11 Page:
ISSN:1941-7640
Container-title:Circulation: Cardiovascular Interventions
language:en
Short-container-title:Circ Cardiovasc Interv

Author:

Elmariah Sammy¹,Doros Gheorghe¹,Benavente Oscar R.¹,Bhatt Deepak L.¹,Connolly Stuart J.¹,Yusuf Salim¹,Steinhubl Steven R.¹,Liu Yuyin¹,Hsieh Wen-Hua¹,Yeh Robert W.¹,Mauri Laura¹

Affiliation:

1. From the Cardiology Division, Department of Medicine, Massachusetts General Hospital (S.E.), Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women’s Hospital (D.L.B., L.M.), Smith Center for Outcomes Research in Cardiology, Department of Medicine, Beth-Israel Deaconess Medical Center (R.W.Y.), Harvard Medical School, Boston, MA (S.E., D.L.B., R.W.Y., L.M.); Baim Institute for Clinical Research, Boston, MA (S.E., G.D., Y.L., W.-H.H., R.W.Y., L.M.); Department of Biostatistics...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. 2014 ESC/EACTS Guidelines on myocardial revascularization

2. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery

3. 19th WHO Model List of Essential Medicines. http://www.who.int/medicines/publications/essentialmedicines/en/. Accessed July 18 2016.

4. Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials.;Udell JA;Eur Heart J,2016

5. Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contemporary Prestroke Dual Antiplatelet Use and Symptomatic Intracerebral Hemorrhage Risk After Thrombolysis;JAMA Neurology;2024-07-01

2. Coronary stent failure: role of a blended approach with drug-coated balloons for complex lesions;Minerva Cardiology and Angiology;2023-03

3. Acute reperfusion treatment and secondary prevention of cancer-related stroke: comprehensive overview and proposal of clinical algorithm;Therapeutic Advances in Neurological Disorders;2023-01

4. Half‐Dose (45 mg Twice Daily) Ticagrelor Versus Clopidogrel in Neuroendovascular Dual Antiplatelet Therapy: A Single‐Center Cohort Study;Stroke: Vascular and Interventional Neurology;2023-01

5. Targeting Platelet Activation Pathways to Limit Tumour Progression: Current State of Affairs;Pharmaceuticals;2022-12-09